| Platinum-based chemotherapy for variant castrate-resistant prostate cancer AM Aparicio, AL Harzstark, PG Corn, S Wen, JC Araujo, SM Tu, ... Clinical cancer research 19 (13), 3621-3630, 2013 | 438 | 2013 |
| Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and … HT Tran, Y Liu, AJ Zurita, Y Lin, KL Baker-Neblett, AM Martin, RA Figlin, ... The lancet oncology 13 (8), 827-837, 2012 | 284 | 2012 |
| Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype Y Piao, J Liang, L Holmes, AJ Zurita, V Henry, JV Heymach, JF De Groot Neuro-oncology 14 (11), 1379-1392, 2012 | 249 | 2012 |
| Cadherin-11 promotes the metastasis of prostate cancer cells to bone K Chu, CJ Cheng, X Ye, YC Lee, AJ Zurita, DT Chen, LY Yu-Lee, S Zhang, ... Molecular Cancer Research 6 (8), 1259-1267, 2008 | 221 | 2008 |
| Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicities SK Subudhi, A Aparicio, J Gao, AJ Zurita, JC Araujo, CJ Logothetis, ... Proceedings of the National Academy of Sciences 113 (42), 11919-11924, 2016 | 212 | 2016 |
| State of the science: an update on renal cell carcinoma E Jonasch, PA Futreal, IJ Davis, ST Bailey, WY Kim, J Brugarolas, ... Molecular cancer research 10 (7), 859-880, 2012 | 196 | 2012 |
| Validation of a standardized method for enumerating circulating endothelial cells and progenitors: flow cytometry and molecular and ultrastructural analyses P Mancuso, P Antoniotti, J Quarna, A Calleri, C Rabascio, C Tacchetti, ... Clinical cancer research 15 (1), 267-273, 2009 | 194 | 2009 |
| Resistance to antiangiogenic therapy is associated with an immunosuppressive tumor microenvironment in metastatic renal cell carcinoma XD Liu, A Hoang, L Zhou, S Kalra, A Yetil, M Sun, Z Ding, X Zhang, S Bai, ... Cancer immunology research 3 (9), 1017-1029, 2015 | 190 | 2015 |
| Androgen receptor–negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms ZG Li, P Mathew, J Yang, MW Starbuck, AJ Zurita, J Liu, C Sikes, ... The Journal of clinical investigation 118 (8), 2697-2710, 2008 | 190 | 2008 |
| Combinatorial screenings in patients: the interleukin-11 receptor α as a candidate target in the progression of human prostate cancer AJ Zurita, P Troncoso, M Cardó-Vila, CJ Logothetis, R Pasqualini, W Arap Cancer research 64 (2), 435-439, 2004 | 174 | 2004 |
| Cabazitaxel plus carboplatin for the treatment of men with metastatic castration-resistant prostate cancers: a randomised, open-label, phase 1–2 trial PG Corn, EI Heath, A Zurita, N Ramesh, L Xiao, E Sei, E Li-Ning-Tapia, ... The lancet oncology 20 (10), 1432-1443, 2019 | 154 | 2019 |
| Targeting neuropilin-1 in human leukemia and lymphoma K Karjalainen, DE Jaalouk, CE Bueso-Ramos, AJ Zurita, A Kuniyasu, ... Blood, The Journal of the American Society of Hematology 117 (3), 920-927, 2011 | 125 | 2011 |
| A cytokine and angiogenic factor (CAF) analysis in plasma for selection of sorafenib therapy in patients with metastatic renal cell carcinoma AJ Zurita, E Jonasch, X Wang, M Khajavi, S Yan, DZ Du, L Xu, MH Herynk, ... Annals of oncology 23 (1), 46-52, 2012 | 123 | 2012 |
| Expression of multidrug resistance proteins P-glycoprotein, multidrug resistance protein 1, breast cancer resistance protein and lung resistance related protein in locally … JE Diestra, E Condom, XG Del Muro, GL Scheffer, J Pérez, AJ Zurita, ... The Journal of urology 170 (4), 1383-1387, 2003 | 119 | 2003 |
| Compositions and methods of use of targeting peptides for diagnosis and therapy W Arap, M Kolonin, R Pasqualini, A Zurita US Patent App. 11/026,999, 2005 | 110 | 2005 |
| Outcomes of patients with metastatic clear-cell renal cell carcinoma treated with second-line VEGFR-TKI after first-line immune checkpoint inhibitors AY Shah, RR Kotecha, EA Lemke, A Chandramohan, JL Chaim, ... European Journal of Cancer 114, 67-75, 2019 | 107 | 2019 |
| Prostate cancer cell–stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastases X Wan, PG Corn, J Yang, N Palanisamy, MW Starbuck, E Efstathiou, ... Science translational medicine 6 (252), 252ra122-252ra122, 2014 | 97 | 2014 |
| Ligand-directed surface profiling of human cancer cells with combinatorial peptide libraries MG Kolonin, L Bover, J Sun, AJ Zurita, KA Do, J Lahdenranta, ... Cancer research 66 (1), 34-40, 2006 | 95 | 2006 |
| Design and validation of a bifunctional ligand display system for receptor targeting L Chen, AJ Zurita, PU Ardelt, RJ Giordano, W Arap, R Pasqualini Chemistry & biology 11 (8), 1081-1091, 2004 | 94 | 2004 |
| Mapping tumor vascular diversity by screening phage display libraries AJ Zurita, W Arap, R Pasqualini Journal of controlled release 91 (1-2), 183-186, 2003 | 93 | 2003 |
